Published on
September 13, 2022
- 12:47 GMT
Altamira Therapeutics Completes Enrollment for COVAMID Trial with Bentrio in Acute COVID-19
HAMILTON, BERMUDA , Sept. 13, 2022 (GLOBE NEWSWIRE) -- Study has reached extended enrollment target of 160 patients Top-line data read-out expected in Q4-22 Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that …
Distribution channels:
Healthcare & Pharmaceuticals Industry
